TLRY, a player in the cannabis market, is higher by 0.25% Friday as it outperforms the market as a whole. The market has been neutral on Tilray Inc (TLRY) stock recently. TLRY gets a Neutral score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With TLRY Stock Today?
Tilray Inc (TLRY) stock is higher by 0.25% while the S&P 500 is lower by -0.05% as of 1:38 PM on Friday, Jun 11. TLRY is up $0.05 from the previous closing price of $20.05 on volume of 16,087,324 shares. Over the past year the S&P 500 has gained 32.82% while TLRY is up 107.43%. TLRY lost -$2.70 per share in the over the last 12 months.
More About Tilray Inc
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.